Intellectual property drives pharmaceutical innovation in emerging markets
Intellectual property reforms ushered in by TRIPS have stimulated a nascent boom in pharmaceutical innovation in middle-income countries.
Pharmaceutical innovation in Mexico: at the crossroads
Mexico has the choice to remain as a low-value manufacturer of medicines, or develop as an innovator in its own right.